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Abstract
Background: Transgenic animals are widely used in biomedical research and biotechnology.
Multicistronic constructs, in which several proteins are encoded by a single messenger RNA, are
commonly used in genetically engineered animals. This is currently done by using an internal
ribosomal entry site to separate the different coding regions. 2A peptides result in the co-
translational 'cleavage' of proteins and are an attractive alternative to the internal ribosomal entry
site. They are more reliable than the internal ribosomal entry site and lead to expression of multiple
cistrons at equimolar levels. They work in a wide variety of eukaryotic cells, but to date have not
been demonstrated to function in transgenic mice in an inheritable manner.
Results: To test 2A function in transgenic mice and uncover any possible toxicity of widespread
expression of the 2A peptide, we made a bicistronic reporter construct containing the coding
sequence for a membrane localised red fluorescent protein (Myr-TdTomato) and a nuclear
localised green fluorescent protein (H2B-GFP), separated by a 2A sequence. When this reporter
is transfected into HeLa cells, the two fluorescent proteins correctly localise to mutually exclusive
cellular compartments, demonstrating that the bicistronic construct is a reliable readout of 2A
function. The two fluorescent proteins also correctly localise when the reporter is electroporated
into chick neural tube cells. We made two independent transgenic mouse lines that express the
bicistronic reporter ubiquitously. For both lines, transgenic mice are born in Mendelian frequencies
and are found to be healthy and fertile. Myr-TdTomato and H2B-GFP segregate to mutually
exclusive cellular compartments in all tissues examined from a broad range of developmental
stages, ranging from embryo to adult. One transgenic line shows X-linked inheritance of the
transgene and mosaic expression in females but uniform expression in males, indicating that the
transgene has integrated into the X chromosome in this line.
Conclusion: The 2A peptide efficiently mediates co-translational cleavage in transgenic mice in
which it has been inherited through the germ-line. Mice expressing it ubiquitously throughout
development and into adulthood appear normal. It is therefore a viable tool for use in genetically
engineered mice and represents a superior alternative to the widely used internal ribosomal entry
site.
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Background
Transgenic animals play a central part in biomedical
research and biotechnology. The ability to genetically
modify mice, either through random genomic integration
by pronuclear injection or through targeted modification
by homologous recombination in embryonic stem cells,
has transformed the field of mouse molecular genetics,
making it now a relatively routine procedure to intervene
genetically to study a biological process or address the
function of a gene. Such transgenic approaches have also
been successfully applied to larger mammals for the pro-
duction of livestock that synthesise human proteins or
possess specific growth characteristics.
It is often advantageous to make transgenic animals that
express multiple genes under the control of a single pro-
moter. This allows the expression of different proteins in
a co-ordinated manner while simplifying the genetics and
reducing the cost, since multiple transgenic lines do not
need to be bred together. Currently, the favoured method
for achieving this is to use an internal ribosomal entry site
(IRES). The IRES was first identified in the encephalomy-
ocarditis virus, a member of the genus Cardiovirus, which
belong to the family of small RNA viruses called Picorna-
viridae [1]. The IRES allows multiple proteins to be made
from a single mRNA transcript as ribosomes bind to the
IRES in a 5'-cap-independent manner and initiate transla-
tion. They can therefore be used to engineer multicistronic
transgenes, in which several open reading frames are
encoded on a single transcript, separated by IRES
sequences. IRES sequences are also commonly used in
gene targeting experiments in mice to express a foreign
gene under the control of an endogenous promoter. In
these cases, the 'knocked-in' foreign gene is preceded by
an IRES, allowing it to be produced as a separate protein,
rather than as a fusion with the protein encoded by the
endogenous gene. In addition to being used in transgenic
mice, IRES sequences are very widely used in tissue-cul-
ture cell transfections, as a means of ensuring cells express
the transfected gene by using constructs in which the gene
of interest is followed by an IRES and a selectable drug
resistance gene or fluorescent marker.
IRES sequences, however, have several limitations: the
expression of the downstream cistron is sensitive to its
specific positioning after the IRES and hence the IRES can
be unreliable; the downstream coding sequence is often
translated at much lower levels than the upstream
sequence; they are not small (approximately 600 base
pairs), adding to the size of the transgene; they do not pro-
vide equivalent levels of expression of the genes separated
by IRES elements. Although efforts continue to be made
to address the first of the above issues [2], the other prob-
lems are harder to address.
Recently, the use of the 2A peptide in multicistronic con-
structs has emerged as an attractive alternative to the IRES.
Like the IRES, the 2A peptide was identified among picor-
naviruses but in a different sub-group, the Aphthoviruses, a
typical example of which is the Foot-and-mouth disease virus
[3]. 2A-like sequences have since been found in other
Picornaviridae like the Equine rhinitis A virus, as well as
unrelated viruses such as the Porcine teschovirus-1 and the
insect Thosea asigna virus (TaV) [4]. In such viruses, multi-
ple proteins are derived from a large polyprotein encoded
by a single open reading frame. The 2A peptide mediates
the co-translational cleavage of this polyprotein at a single
site that forms the junction between the virus capsid and
replication polyprotein domains.
The 2A sequences are relatively short peptides (of the
order of 20 amino acids long, depending on the virus of
origin) containing the consensus motif Asp-Val/Ile-Glu-X-
Asn-Pro-Gly-Pro. They were originally thought to mediate
the autocatalytic proteolysis of the large polyprotein, but
are now understood to act co-translationally, by prevent-
ing the formation of a normal peptide bond between the
glycine and last proline, resulting in the ribosome skip-
ping to the next codon [5], and the nascent peptide cleav-
ing between the Gly and Pro. After cleavage, the short 2A
peptide remains fused to the C-terminus of the 'upstream'
protein, while the proline is added to the N-terminus of
the 'downstream' protein. It has recently been shown that
translation termination release factors eRF1 and eRF3 play
an important role in the function of the 2A peptide [6].
Due to its mode of action, the 2A peptide is described as a
'cis-acting hydrolase element' (CHYSEL) [7].
The 2A peptide was demonstrated to efficiently mediate
the co-translational cleavage of artificial polypeptides by
inserting it between the coding sequences of two reporter
genes [8]. Subsequently, it has been shown to function in
cells from a wide variety of eukaryotes, ranging from yeast
to plants to insects to mammals [7]. The 2A peptide was
first shown to work in vivo in the rat brain, using recom-
binant adeno-associated viruses containing 2A dependent
vectors [9]. More recently, a striking demonstration of its
potential has been to use it to reconstitute the expression
of the multisubunit T-cell receptor:CD3 complex in bone
marrow-derived stem cells transduced with retroviral vec-
tors carrying up to four CD3 genes separated by 2A
sequences [10,11]. When transplanted back into CD3-
deficient mice, these transduced stem cells gave rise to T
cells, demonstrating 2A function. The 2A peptide was also
shown to function in derivatives of the transduced stem
cells (in the spleen, thymus and blood) and to result in
stoichiometric co-expression of multiple proteins [10].
The many advantages of the 2A peptide in biotechnology
have been reviewed by de Felipe and colleagues [12].BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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Although the 2A peptide has been shown to function in a
wide variety of cell types and in specific tissues in vivo, it
has to date not been demonstrated to function in a perma-
nent transgenic mouse line after passage through the
germ-line, to test for possible silencing of 2A-containing
transgenes. Moreover, it is not known if there might be
possible toxic side-effects of the 2A peptide upon wide-
spread continuous expression at various stages of develop-
ment. Therefore, we have made transgenic mouse lines
that express a 2A-containing construct essentially ubiqui-
tously throughout development and adulthood. We
report that such mice appear normal and healthy, and that
the 2A peptide functions in all tissues at all stages exam-
ined in such mice.
Results and discussion
Constructing a fluorescent reporter of 2A function
We designed a strategy to enable us to assess visually 2A
function using fluorescent proteins localised to two dis-
tinct cellular compartments. We linked a membrane local-
ised TdTomato gene (Myr-TdTomato) to a nuclear localised
enhanced green fluorescent protein (EGFP) gene (H2B-
GFP) using the 2A sequence of the TaV that has previously
been used to efficiently mediate the cleavage of polypro-
teins [10]. TdTomato fluoresces red and EGFP fluoresces
green, allowing one to distinguish them unambiguously.
As a negative control, we made an identical fusion con-
struct, but with two nucleotide changes that abolish 2A
function [10]. These two versions of the construct were
called Tom-2A-GFP and Tom-m2A-GFP, respectively (Fig-
ure 1A).
We tested both constructs by expressing them in HeLa
cells under the control of a CMV-IE promoter. In cells
lipofected with Tom-2A-GFP, EGFP was detected exclu-
sively in the nucleus while TdTomato was detected pre-
dominantly in the plasma membrane, and at lower levels
within the cell, presumably in membrane organelles or
the cytoplasm (Figure 1B–B"). In contrast, in cells lipo-
fected with Tom-m2A-GFP (the mutant construct), EGFP
was detected in the plasma membrane and cytoplasm in
addition to the nucleus (Figure 1C). Similarly, TdTomato
was detected in both the plasma membrane and nucleus
(Figure 1C'), demonstrating that the mutually exclusive
localisation of TdTomato and EGFP seen with the Tom-
2A-GFP construct is a reliable readout of 2A function.
In order to confirm that the Tom-2A-GFP construct
worked not only in cultured cells but also in endogenous
vertebrate cells, we electroporated it into the neural tube
of chick embryos, labelling delaminating neural crest
cells. In confirmation of the results with the HeLa cells,
EGFP localised to the nucleus and TdTomato to the
plasma membrane in electroporated cells, indicating that
the 2A peptide functions in chick cells (Figure 2).
Production of mice transgenic for Tom-2A-GFP
Having established that the Tom-2A-GFP construct is a
reliable indicator of 2A function, we made a transgene in
which it is expressed under the control of the CAG pro-
moter. The CAG promoter drives expression widely in the
mouse [13], allowing us to assess 2A function and possi-
ble deleterious effects in a wide range of tissue types and
developmental stages. Transgenic mice were made by pro-
nuclear injection and two transgenic founders called
CAG-TAG1 and CAG-TAG2 were obtained. Both founders
were bred to establish permanent lines.
The transgene is expressed in both lines and is inherited in
a Mendelian manner, suggesting that it does not cause
embryonic or perinatal lethality. Transgenic mice of both
lines are indistinguishable from their non-transgenic lit-
termates, suggesting that the widespread expression of the
2A peptide has no deleterious effects on the health of
transgenic mice in either of these two independent lines.
CAG-TAG2 shows an X-linked mode of inheritance, indi-
cating the transgene integrated into the X chromosome.
Both lines were further characterised, as described below.
Function of the 2A peptide in transgenic embryos
To assess 2A function after being inherited through the
germ-line, we first looked in heterozygous embryos that
were two generations removed from the original founder
transgenic mouse. Embryos from both transgenic lines
showed widespread expression of the Tom-2A-GFP, as
expected from the CAG promoter used (Figure 3). Robust
levels of fluorescence were detected in both living as well
as fixed samples from both transgenic lines.
In both lines, at all pregastrulation stages, EGFP is local-
ised exclusively to the nucleus, while TdTomato is present
predominantly in the plasma membrane (Figure 4 and
data not shown for CAG-TAG2 embryos). Fluorescence is
first detected at the two-cell stage when the transgene is
inherited paternally. Embryos that inherit the transgene
maternally show fluorescence as zygotes, due to the inher-
itance of maternal RNA (data not shown).
Interestingly, at the blastocyst stage, TdTomato is
expressed widely in the cytoplasm of cells of the inner cell
mass (ICM), even though in adjacent trophectoderm cells,
it is seen mostly in the plasma membrane. This might
reflect differences between trophectoderm and ICM cells
in the processing of myristoylated proteins. TdTomato is
never detected in the nucleus and EGFP never in the cyto-
plasm or plasma membrane, confirming that it is being
cleaved from the H2B-GFP in both ICM and trophecto-
derm cells.BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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Testing 2A constructs in HeLa cells Figure 1
Testing 2A constructs in HeLa cells. (A) Constructs Tom-2A-GFP and Tom-m2A-GFP used to test the function of the 2A 
linker. A membrane localised red fluorescent protein (Myr-TdTomato) linked to a nuclear localised green fluorescent protein 
(H2B-GFP) by either a functional 2A linker (top), or by a non-functional m2A linker (bottom). The specific nucleotide and 
amino acid changes made in Tom-m2A-GFP are shown in red. (B-B") HeLa cells lipofected with Tom-2A-GFP. Fluorescent cells 
show segregation of the TdTomato and enhanced green fluorescent protein (EGFP) to mutually exclusive cellular compart-
ments. (C-C") HeLa cells lipofected with Tom-m2A-GFP as a negative control. The EGFP and TdTomato are no longer segre-
gated properly, consistent with them remaining linked together as a single fusion protein due to the mutations in the 2A linker. 
(B, C) EGFP fluorescence. (B', C') TdTomato fluorescence. (B", C") Merge of EGFP (green) and TdTomato (magenta) fluores-
cence. Diagram in (A) not to scale. The scale bar in (B) represents 50 μm and applies to panels B through C".BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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Testing the Tom-2A-GFP construct in chick embryos Figure 2
Testing the Tom-2A-GFP construct in chick embryos. (A-C) Three-dimensional volume rendering of a confocal image 
stack of embryonic chick neural crest cells electroporated with the Tom-2A-GFP construct under the control of a CMV 
enhancer. The enhanced green fluorescent protein (EGFP) and TdTomato segregate to the nucleus and plasma membrane 
respectively, indicating that the 2A peptide functions in chick cells. (A) EGFP fluorescence. (B) TdTomato fluorescence. (C) 
Merge of EGFP (green) and TdTomato (magenta) fluorescence. Scale indicators are rendered in perspective along with the 
confocal image data and do not translate reliably to a two-dimensional image, therefore, no scale bar is depicted. As an approx-
imate indicator, the two cells at the right of the image that have just divided are, together, between 15 and 20 μm long.BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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Mutually exclusive localisation of EGFP and TdTomato to
the nucleus and membrane was also observed in tissues
derived from all three germ-layers at later embryonic
stages, such as E8.5 (Figure 5), E11.5 and E18.5 (data not
shown). In order to verify independently that the EGFP
was indeed localised to the nucleus, we stained tissue sec-
tions with the nuclear dye 4',6-diamidino-2-phenylindole
(DAPI), which confirmed the nuclear localisation of EGFP
(Figure 5C and 5D). Similarly, a phalloidin stain (which
labels sub-cortical actin filaments), verified the localisa-
tion of TdTomato to the plasma membrane (Figure 5C'
and 5D'). We, however, cannot exclude the possibility
that extremely small amounts of un-cleaved protein,
below the detection capability of our confocal micro-
scope, are produced and incorrectly localised.
Function of the 2A peptide in adult transgenic mice
We next assessed 2A function in various tissues from male
adult heterozygous transgenic mice that were three gener-
ations removed from the original founder mouse. H2B-
GFP and Myr-TdTomato were localised to mutually exclu-
sive cellular compartments in all the tissues examined: the
brain, heart, lung, liver, kidney, ileum, colon and adrenal
(Figure 6 and data not shown) for both transgenic lines.
In cells of the cardiac muscle, intestine and kidney, TdTo-
mato was found to localise to the plasma membrane.
However, in cells of the lungs and liver, it was less dis-
tinctly localised to the plasma membrane (Figure 6B, B', C
and 6C'), as previously observed with cells of the embry-
onic ICM. Again, TdTomato and EGFP were never found
to co-localise in the two independent transgenic lines,
indicating efficient cleavage of the 2A peptide.
Mosaic transgene expression in female CAG-TAG2 mice
The CAG-TAG2 transgene shows an X-linked mode of
inheritance, indicating that the transgene integrated in the
X chromosome. Consistent with this, females of the CAG-
TAG2 line show mosaic expression due to X inactivation
(Figure 7), while males show uniform expression (as in
both genders of the CAG-TAG1 line). Both genders, how-
ever, show the correct subcellular localisation of TdTo-
mato and EGFP, demonstrating that the 2A peptide
functions in both transgenic lines.
Expression levels of the CAG-TAG transgene is constant 
across generations
In order to determine if there is any variability of expres-
sion levels of the CAG-TAG transgene across individuals
Widespread expression of Tom-2A-GFP in transgenic embryos Figure 3
Widespread expression of Tom-2A-GFP in transgenic embryos. An E11.5 mouse embryo transgenic for Tom-2A-GFP 
under the control of a CAG promoter is shown. (A) Brightfield image, (B) Enhanced green fluorescent protein (EGFP) fluores-
cence and (C) TdTomato fluorescence. EGFP and TdTomato can be seen to be expressed throughout the embryo. Fluores-
cence intensity of both EGFP and TdTomato is higher in regions of relatively greater tissue density. The scale bar in (A) 
represents 1 mm and applies to all panels.BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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Function of 2A peptide in pregastrulation embryos Figure 4
Function of 2A peptide in pregastrulation embryos. (A-A") E2.5, (B-B") E4.0 and (C-C") E5.5 embryos expressing Tom-
2A-GFP ubiquitously under the control of a CAG promoter. The embryos shown represent the F2 generation with respect to 
the founder F0 transgenic mouse. In all the embryos shown, the transgene was inherited from a heterozygous father. Cells in 
both embryonic as well as extra-embryonic tissues show segregation of TdTomato and enhanced green fluorescent protein 
(EGFP) to mutually exclusive cellular compartments, indicating 2A function in both lineages. (A, B, C) EGFP fluorescence. (A', 
B', C') TdTomato fluorescence. (A", B", C") Merge of EGFP (green) and TdTomato (magenta) fluorescence. The scale bar in (A) 
represents 50 μm and applies to all panels.BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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Function of 2A peptide in E8.5 embryos Figure 5
Function of 2A peptide in E8.5 embryos. (A-A") Transverse section through an E8.5 transgenic embryo. (B-B") Trans-
verse section through the neural tube of an E8.5 transgenic embryo. Note the 'ring' of dividing cells lining the inside of the neu-
ral tube. (C-D") High magnification view of neural tube cells expressing Tom-2A-GFP, stained with 4',6-diamidino-2-
phenylindole (DAPI) (nucleus) and phalloidin (sub-cortical actin marking plasma membrane), confirming that enhanced green 
fluorescent protein (EGFP) and TdTomato are expressed in mutually exclusive compartments, in the nucleus and plasma mem-
brane respectively. (A, B, C) EGFP fluorescence. (A', B', C') TdTomato fluorescence. (A", B", C") Merge of EGFP (green) and 
TdTomato (magenta) fluorescence. (D) DAPI fluorescence. (D') Atto647N-phalloidin fluorescence. (D") Merge of DAPI 
(green) and Atto647N (magenta). The scale bar in (A) represents 63 μm in (A-A"), 31 μm in (B-B") and 10 μm in (C-D").BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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or diminution of expression across generations, we quan-
tified the fluorescence intensity of TdTomato as an esti-
mate of its expression level. We compared expression in
cardiac tissue from the CAG-TAG1 founder (F0), F1, F2
and F3 adult male mice (Figure 8). Transgene expression
levels were very similar in the F1, F2 and F3 individuals,
showing no statistically significant difference. This sug-
gests the expression levels of the CAG-TAG1 transgene
does not vary significantly across individuals, and more
importantly, does not show a reduction with repeated
passage through the germ-line.
The founder mouse showed a lower median expression
level compared with his offspring. This is consistent with
the founder being mosaic for the transgene, which is not
uncommon in transgenic founders. It is also consistent
with the observation that the cardiac tissue from the
founder showed mosaic transgene expression (data not
shown). It is important to note that those regions of
founder tissue that did express the transgene appear to
have done so at levels comparable with that found in the
offspring, as illustrated by the overlap of the upper quar-
tile of fluorescence intensities observed in the founder,
with that observed in his offspring (Figure 8).
Conclusion
Our results indicated that the 2A peptide does not pro-
duce cytotoxic effects in transgenic mice that express it in
all their cells throughout development and adulthood.
They also indicate that the 2A peptide functions in trans-
genic mice after several generations of passage through the
germ-line and transgenes encoding the 2A peptide do not
show attenuation in expression levels across generations.
Our results also confirmed that the 2A peptide mediates
co-translational 'cleavage' in a wide range of embryonic
and adult tissues.
Together, this establishes the 2A peptide as a viable and,
being more reliable and easier to use, a superior alterna-
tive to the IRES in mouse transgenesis. It fulfils all the
functions IRES sequences are currently used for: multicis-
tronic expression in transgenic animals and cell culture,
multicistronic expression using viral vectors in entire ani-
mals, expression of exogenous coding sequences inserted
by targeted recombination into endogenous loci, etc. In
addition, it also provides the advantage of reliable and
stoichiometric levels of expression, making it particularly
useful when the relative level of expression of two or more
transgenic proteins is important.
Finally, the transgenic mice reported here are useful in
their own right for visualising cell membranes and nuclei
in living and fixed tissue. Owing to the widespread expres-
sion of the CAG-TAG transgene, the mice are likely to be
of use in a broad range of disciplines. In conjunction with
time-lapse microscopy, they represent a powerful tool for
following various cellular parameters such as shape, vol-
ume, movement and division rates in cultured cells,
organs or entire embryos. The fortuitous insertion of the
transgene in the X chromosome in one of the transgenic
Function of 2A peptide in various adult tissues Figure 6
Function of 2A peptide in various adult tissues. Sections through the heart (A, A'), lung (B, B'), liver (C, C'), kidney (D, 
D') and intestine (E, E') of adult CAG-TAG1 and CAG-TAG2 transgenic mice. The enhanced green fluorescent protein signal is 
depicted in green and TdTomato signal is depicted in magenta. No overlap of the H2B-GFP and Myr-TdTomato signal is seen, 
demonstrating efficient functioning of the 2A peptide. The scale bar in (A) represents 20 μm and is applicable to all panels.BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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Mosaic expression of CAG-TAG2 due to X inactivation Figure 7
Mosaic expression of CAG-TAG2 due to X inactivation. Sections through the heart of an adult female (A, A', and A") 
and male (B, B' and B") CAG-TAG2 mouse are shown. (A, B) Td-Tomato fluorescence showing expression of the transgene. 
(A', B') Atto647N-phalloidin fluorescence used as a 'counter-stain' to visualise all the tissue in the field of view. (A", B") Merge 
of TdTomato (red) and phalloidin (green) fluorescence, illustrating the mosaic expression of the CAG-TAG transgene in 
females due to X inactivation, but uniform expression in males. The scale bar in (A) represents 100 μm and is applicable to all 
panels.BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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lines makes that line particularly useful in monitoring X
chromosome inactivation.
Methods
Plasmids and constructs
pCS-mCherry (a gift from Sean Megason) contains two
tandem copies of a myristoylation signal in frame with
mCherry, which targets mCherry to the membrane. We
replaced the mCherry  in this plasmid with TdTomato
cloned from plasmid pSET-B-tdTomato (a gift from Roger
Tsien), because of its increased brightness and photosta-
bility [14]. While replacing mCherry with TdTomato, we
destroyed a Kozak consensus sequence between the myr-
istoylation sequence and the initiation codon of mCherry,
in order to increase the probability that translation would
initiate at another Kozak site upstream of the two myris-
toylation sequences, thereby reducing possible cytoplas-
mic 'background' localisation.
TdTomato was polymerase chain reaction-amplified using
one forward primer and two different reverse primers, one
encoding the normal 2A peptide and the other the non-
cleavable mutant 2A peptide (referred to here as m2A)
[10]. Both reverse primers omitted the TdTomato  stop
codon, so that translation could continue into the 2A
sequence and beyond. To facilitate subsequent cloning,
the forward primer incorporated an AgeI site, and the two
lower primers incorporated a BglII and SnabI site. pCS-
mCherry was digested with AgeI and SnabI to remove
mCherry and replaced with amplified TdTomato-2A  or
Expression levels of CAG-TAG1 transgene across four generations Figure 8
Expression levels of CAG-TAG1 transgene across four generations. TdTomato fluorescence intensity was used as a 
measure of transgene expression levels. TdTomato fluorescence was quantified in cardiac tissue from the CAG-TAG1 male 
founder (F0), and from his F1, F2, and F3 male adult offspring. The plot represents the distribution of average TdTomato fluo-
rescence intensity per pixel for 10 different fields of view for each sample. F1, F2 and F3 mice express the transgene at equiva-
lent levels. They do not show a significant difference in expression levels (Student t-test, P > 0.1 for all three combinations of 
pair-wise comparisons of the three samples). The founder has a broader distribution of average intensity per pixel and shows a 
lower minimum value than the others because he was mosaic for the transgene, and some of the fields of view measured had 
regions that did not express the transgene, causing a lowering of the average pixel intensity.BMC Biology 2008, 6:40 http://www.biomedcentral.com/1741-7007/6/40
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TdTomato-m2A  digested with the same enzymes. The
resulting plasmids were called pCS-TdTomato-2A and
pCS-TdTomato-m2A.
Next H2B-GFP was cut out of plasmid pCAG-H2B-GFP-
STP (a gift from Shahragim Tajbakhsh) with BglII and
NotI and cloned in frame downstream of TdTomato-2A
and TdTomato-m2A. The resulting plasmids called pCS2-
TdTomato-2A-GFP and pCS2-TdTomato-m2A-GFP were
tested by lipofection in HeLa cells.
To make the transgene construct for pronuclear injection,
TdTomato-2A-GFP  was excised with XhoI (made blunt
with Klenow) and NotI and inserted downstream of the
CAG promoter of pCAG-H2B-GFP-STP cut with EcoRV
and NotI. A linear fragment for injection containing CAG-
TdTomato-2A-GFP was excised with XhoI and NotI.
Primers
Forward primer:
5' GCA CCG GTC GCC TCC ATG GTG AGC AAG GGC
GAG GAG GTC ATC 3'
2A reverse primer:
5' C CTA CGT AAG ATC TCC TGG GCC AGG ATT CTC
CTC GAC GTC ACC GCA TGT TAG CAG ACT TCC TCT
GCC CTC TCC ACT GCC CTT GTA CAG CTC GTC CAT
GCC GTA CAG 3'
m2A reverse primer:
5' C CTA CGT AAG ATC TCC TGG GGC AGC ATT CTC
CTC GAC GTC ACC GCA TGT TAG CAG ACT TCC TCT
GCC CTC TCC ACT GCC CTT GTA CAG CTC GTC CAT
GCC GTA CAG 3'
Underlined regions of the reverse primers encode the 2A
(or m2A) peptide.
Lipofection
pCS2-TdTomato-2A-GFP and pCS2-TdTomato-m2A-GFP
were lipofected into HeLa cells using Lipofectamine-2000
from Invitrogen according to the manufacturer's protocol;
50 ng of plasmid DNA was used per well of a 24-well
plate.
Chick electroporation
pCS2-TdTomato-2A-GFP at 2 μg/μl was electroporated in
ovo into the neural tube of chick embryos at stage HH 12
using four 5-ms pulses of 10 V. Electroporated embryos
were incubated for 24 hours at 38°C, then dissected, fixed
and scanned using a confocal microscope.
Transgenic mice and breeding
For pronuclear injection into mouse zygotes, the trans-
gene was excised by restriction enzyme digest and gel puri-
fied using the Qiagen gel purification kit according to the
manufacturer's recommendations, except that the DNA
was eluted directly with injection buffer (10 mM Tris-Cl,
0.1 mM ethylenediaminetetraacetic acid). The transgene
DNA was diluted to a concentration of 3.0 ng/μl and used
for pronuclear injection into [B6xCBA]F2 mouse zygotes
as described [15]. Potential transgenic mice were screened
by examining tail-tip biopsies under a fluorescence stere-
omicroscope (Zeiss StereoLumar), and transgenic mice
were bred to [B6xCBA]F1 mice (Harlan) to establish per-
manent lines.
Embryo and tissue collection, sectioning and staining
To produce staged embryos, transgenic males were
crossed to wild type CD1 females (Charles River). All mice
were maintained on a 12 hour light, 12 hour dark cycle.
Noon on the day of finding a vaginal plug was designated
0.5 dpc. Embryos of various stages and tissues from adult
mice were dissected in M2 medium and fixed in 4% para-
formaldehyde in phosphate buffered saline (PBS) over-
night. Samples were then washed in PBT (PBS + 0.1%
Triton-X100) several times and then either mounted
whole in DAPI-Vectashield (Vector Laboratories, H-1200)
or processed for cryosectioning. Samples for sectioning
were incubated in 30% sucrose in PBS at 4°C overnight.
They were then embedded in a solution of 15% sucrose
and 7.5% gelatin in PBS and frozen in isopentane main-
tained at -55°C. Frozen sections were cut at 30 μm thick-
ness at -25°C. Sections were washed three times for 5
minutes each in PBT, incubated for 30 minutes with
Atto647N-phalloidin (Sigma – 65906) diluted 1:200 in
PBT, washed five times for 5 minutes each in PBT and then
mounted in DAPI-Vectashield.
Image data colletion
The lipofected cells in Figure 1 were imaged on an Impro-
vision spinning disc microscope with a Yokagawa CSU10
head and a Hamamatsu EM-CCD camera mounted on a
Zeiss inverted microscope, using a ×40/0.6 NA air objec-
tive. EGFP was excited at 492 nm and TdTomato at 561
nm.
Fixed samples were imaged on Zeiss LSM510 META and
Zeiss LSM 710 confocal microscopes using ×10/0.45 NA,
×20/0.75 NA, ×40/1.3 NA or ×63/1.4 NA lenses as appro-
priate. EGFP was excited at 488 nm; TdTomato was
excited at 543 nm; DAPI was excited at 405 nm; and
Atto647N-phalloidin was excited at 633 nm. All image
analysis and three-dimensional rendering was done using
Volocity (Improvision, UK). Figures were prepared using
Photoshop CS2 (Adobe Inc.).Publish with BioMed Central    and   every 
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Fluorescence quantification
For TdTomato fluorescence intensity quantification, all
samples were collected at the same time and processed
identically. Frozen sections of cardiac muscle tissue were
scanned as above, at 12 bit depth under non-saturating
conditions. The average intensity per pixel was measured
for 10 random fields of view for each sample, using
ImageJ. Keliadegraph was used to plot the distribution of
intensities and to determine the significance of any varia-
bility between the samples using the Students t-test.
List of abbreviations
DAPI: 4',6-diamidino-2-phenylindole; EGFP: enhanced
green fluorescent protein; ICM: inner cell mass; IRES:
internal ribosomal entry site; PBS: phosphate buffered
saline; PBT: PBS + 0.1% Triton-X100; TaV: Thosea asigna
virus
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